Brief: Baijin Life Science Expects Net Profit Of HK$2.5 Million For HY
25/11/2025 10:23
Nov 25 (Reuters) - Baijin Life Science Holdings Ltd 1466.HK: EXPECTS NET PROFIT OF HK$2.5 MILLION FOR HY EXPECTED HY RESULTS DUE TO GAIN ON CONVERTIBLE BOND VALUE CHANGE Further company coverage: 1466.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baijin Life Science Holdings
See all newsBrief: Baijin Life Science Says Unit Enters Strategic Cooperation Framework Agreement With Foryoung Biotechnology
Brief: Baijin Life Science Says Unit To Invest In Guhuan Medical For Sales Channel
Brief: Baijin Life Science Expects Net Profit Of HK$2.5 Million For HY
Brief: Baijin Life Science Says Beijing Baijin To Invest In Youhuan Bio For Circrna Platform
Brief: Baijin Life Science Enters Subscription Agreements For Aggregate Of 40 Million Shares At HK$0.48 Per Share